相关实验视频

Updated: Jul 14, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

作为hEGFR抑制剂的1,2,4-二醇-乙胺结合物:合成,抗癌评估和在研究中

Bahadır Bülbül¹, Necla Kulabaş², Merve Gürboğa³

¹Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Düzce University, Konuralp Campus, Düzce, Türkiye.

Chemistry & biodiversity

|January 14, 2026

概括

新的1,2,4-三乙胺衍生物显示出强大的抗癌活性. 化合物24显示出高于gefitinib的疗效,而化合物20强烈抑制了人类表皮生长因子受体 (hEGFR).

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

癌症仍然是全球主要的死亡原因,需要开发新的治疗药物.
针对像人类表皮生长因子受体 (hEGFR) 这样的受体氨酸激酶是癌症治疗中经过验证的策略.
1,2,4-三衍生物已经显示出作为抗癌剂的前景.

研究的目的:

合成和评估新型1,2,4-triazole-acetamide衍生物的抗癌和hEGFR抑制潜力.
为了识别具有高强度和对癌症细胞系和hEGFR.高选择性的化合物.

主要方法:

1,2,4-二醇-乙胺衍生物的多步合成.
使用光谱方法进行表征.
在实验室中对PC-3,MCF-7,A549和K562癌细胞系进行细胞毒性测定.
检测hEGFR抑制的体外激酶试验.
分子对接和分子动力学模拟.

主要成果:

化合物18,19和24表现出显著的抗增殖作用.
与gefitinib相比,化合物24显示出更高的选择性和强度,诱导细胞亡并抑制A549和PC-3细胞的迁移.
化合物20成为最强大的hEGFR抑制剂,其IC50为43.8 ± 1.3nM.
分子模拟证实了化合物20与EGFR的稳定结合,与Cys797.7相互作用.

结论:

合成的1,2,4-triazole-acetamide衍生物作为抗癌剂具有显著的前景.
化合物20和24被确定为进一步开发EGFR向治疗的潜在候选物.
这项研究为合理设计新型EGFR抑制剂提供了坚实的基础.

关键词:

一,二,四-三醇是什么灭症 (apoptosis) 是一种死亡的过程.癌症癌症癌症癌症癌症作为hEGFR抑制剂的使用.分子动力学分子动力学

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...